Board of directors (19)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (13)
Company facts
- Chair
- Terrence A. Duffy
- In S&P 500 since
- Aug 2006
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC industry
- Security & Commodity Brokers, Dealers, Exchanges & Services
- SEC filings
- EDGAR
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Julie Winkler Sr MD Chief Commercial Officer | Sale | 10,079 | $305.15 | $3.1M |
| Nov 2, 2026 | Howard J. Siegel Director | Sale | 2,000 | $303.00 | $606K |
| Oct 27, 2026 | Sunil Cutinho Chief Information Officer | Sale | 5,000 | $298.70 | $1.5M |
| Oct 22, 2026 | Martin J. Gepsman Director | Sale | 400 | $302.50 | $121K |
| Sep 25, 2026 | William R. Shepard Director | Buy | 293 | $268.76 | $79K |
| Sep 14, 2026 | Elizabeth A. Cook Director | Sale | 500 | $280.11 | $140K |
| Sep 10, 2026 | Terrence A. Duffy Chairman and CEO | Sale | 628 | $275.03 | $173K |
| Sep 10, 2026 | Terrence A. Duffy Chairman and CEO | Sale | 14,372 | $274.41 | $3.9M |
| Jun 25, 2026 | William R. Shepard Director | Buy | 325 | $230.57 | $75K |
| Jun 25, 2026 | William R. Shepard Director | Buy | 14 | $230.57 | $3K |
| May 18, 2026 | Hilda Harris Piell Sr MD & Chief HR Officer | Sale | 5,753 | $304.63 | $1.8M |
| May 15, 2026 | Terrence A. Duffy Chairman and CEO | Sale | 9,004 | $299.58 | $2.7M |
| May 15, 2026 | Terrence A. Duffy Chairman and CEO | Sale | 25,996 | $298.14 | $7.8M |
| Mar 26, 2026 | William R. Shepard Director | Buy | 62 | $297.38 | $18K |
| Mar 26, 2026 | William R. Shepard Director | Buy | 1,408 | $297.38 | $419K |
| Mar 17, 2026 | Jonathan L. Marcus Sr MD General Counsel | Sale | 3,291 | $333.37 | $1.1M |
| Mar 12, 2026 | Ken Vroman Chief Transformation Officer | Sale | 5,160 | $309.00 | $1.6M |
| Mar 6, 2026 | Elizabeth A. Cook Director | Sale | 1,000 | $320.00 | $320K |
| Feb 23, 2026 | Bryan T. Durkin President | Sale | 4,200 | $309.65 | $1.3M |
| Feb 20, 2026 | Martin J. Gepsman Director | Sale | 300 | $305.90 | $92K |
| Feb 6, 2026 | Dennis Suskind Director | Sale | 748 | $300.00 | $224K |
| Dec 30, 2025 | William R. Shepard Director | Buy | 11 | $278.37 | $3K |
| Dec 30, 2025 | William R. Shepard Director | Buy | 251 | $278.37 | $70K |
| Dec 11, 2025 | Terrence A. Duffy Chairman and CEO | Sale | 13,089 | $269.10 | $3.5M |
| Dec 11, 2025 | Terrence A. Duffy Chairman and CEO | Sale | 11,911 | $270.05 | $3.2M |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Sep 9, 2026
As described in the attached press release, CME Group Inc. (“CME Group” or the “Company”) announced new senior leadership appointments in its finance and legal divisions. Jack Tobin, 63, will be appointed to the role of Managing Director, Deputy Chief Financial Officer as of November 2, 2026. Mr. Tobin has served as Managing Director and Chief Accounting Officer since 2015. He most recently served as Managing Director, Corporate Finance since 2007. Prior to our merger with CBOT Holdings, Mr. Tobin served as the Director, Corporate Finance for CBOT Holdings and CBOT from 2002 to 2007. Prior to joining CBOT, Mr. Tobin served as a principal consultant with PricewaterhouseCoopers from 1997 to 2002. Mr. Tobin is a registered certified public accountant. Mr.
Read the 8-K filing - Jun 17, 2026
Chief Executive Officer Leadership Transition On June 17, 2026, CME Group Inc. (the “Company”) announced that Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman, and Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive Officer (the “Leadership Transition”). The Leadership Transition was approved by the Board of Directors on June 16, 2026 and will become effective on the later of March 1, 2027, and the date on which the Company files its Annual Report on Form 10-K with respect to 2026 (the “Transition Date”). Mr. Duffy will continue to serve as the Company’s Chief Executive Officer through the Transition Date and will then serve as the Company’s Executive Chairman from the Transition Date through December 31, 2027. Ms.
Read the 8-K filing - Sep 11, 2025
On September 9, 2025, Jack Tobin, the Managing Director and Chief Accounting Officer of CME Group Inc. (the Company) notified the Company of his decision to retire from the Company. Mr. Tobin will remain in his role as Chief Accounting Officer until October 30, 2026. Mr. Tobin has served in the Chief Accounting Officer role since 2015 and has been with the Company for more than 23 years. His retirement is voluntary and not due to any disagreements regarding the Company's accounting, operations, policies or practices. The Company will initiate a search of potential candidates for the role and Mr. Tobin will work with his successor to support a smooth transition of responsibilities.
Read the 8-K filing - Nov 7, 2024
As described in the attached press release, on November 6, 2024, the Board of Directors (the “Board”) of CME Group Inc. (“CME Group” or the “Company”), based on the recommendations of the Nominating and Governance Committee and the Compensation Committee, approved a further amended and restated employment agreement (the “Amended Agreement”) with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer, which extends Mr. Duffy’s current term of employment until December 31, 2026. Except as described below, the principal terms of the Amended Agreement are substantially the same as his predecessor employment agreement. The Amended Agreement is intended to secure Mr. Duffy’s continued leadership. The Board continues to believe that Mr.
Read the 8-K filing - Jul 8, 2024
As described in the attached press release, Michael G. Dennis will be joining CME Group Inc. (the “CME Group” or the “Company”) as of August 5, 2024 in the role of Senior Managing Director Global Head, Fixed Income. In connection with his acceptance of the offer of employment at CME Group, on July 8, 2024, Mr. Dennis notified the Company of his intent to retire from the Company’s Board of Directors, effective immediately. Mr. Dennis’ decision to resign from the Board of Directors did not involve any disagreement with the Company, the Company’s management or the Board of Directors. Mr. Dennis has served as a member of the CME Group Board of Directors since 2020 and was elected by our Class B-2 shareholders. In the Company’s most recent election of Class B-2 directors in May 2024, there were no additional nominees presented for election, other than Patrick W.
Read the 8-K filing - Mar 7, 2024
CME Group Omnibus Stock Plan On March 4, 2024, the Compensation Committee (the “Committee”) of CME Group Inc. (“CME Group” or the “Company”) approved an amended and restated Omnibus Stock Plan (the “Amended Omnibus Stock Plan”) effective as of March 1, 2024. The amendments to the Amended Omnibus Stock Plan were approved by the Committee to adopt double trigger change of control vesting provisions to align more closely with market practice and the preferences of CME Group shareholders.
Read the 8-K filing - Dec 6, 2023
On December 6, 2023, the Compensation Committee of the Board of Directors (the “Board”) of CME Group Inc. (the “Company”) recommended and the Board approved an amended and restated employment agreement (the “Amended Agreement”) with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer, which extends Mr. Duffy’s current term from December 31, 2024 to December 31, 2025 with principal terms substantially the same as his existing agreement. The Amended Agreement is intended to secure Mr. Duffy’s continued leadership. The Board continues to believe that Mr. Duffy’s strategic and innovative direction and in-depth knowledge of our business and the industry make him uniquely qualified to continue to lead the Company and to execute on our strategy for long-term shareholder value creation.
Read the 8-K filing - Nov 13, 2023
John Pietrowicz Retirement Agreement On February 17, 2022, CME Group Inc. (“CME Group” or the “Company”) filed a Current Report on Form 8-K announcing that John W. Pietrowicz planned to retire from the position of Chief Financial Officer in 2023. On February 28, 2023, the Company filed a Current Report on Form 8-K announcing that Mr. Pietrowicz would retire from his position as Chief Financial Officer and Lynne Fitzpatrick would assume the role of Chief Financial Officer effective as of April 1, 2023. The Company also announced in that report that Mr. Pietrowicz would remain employed by the Company until December 31, 2023 in the role of Special Advisor. In connection with Mr. Pietrowicz’s retirement, the Company and Mr. Pietrowicz entered into a Retirement Agreement, effective as of November 8, 2023 (the “Retirement Agreement”). Under the terms of the Retirement Agreement, Mr.
Read the 8-K filing - Mar 30, 2023
On March 30, 2023, CME Group Inc. (“CME Group” or the “Company”) announced that Sean Tully, Senior Managing Director Global Head Rates & OTC Products, will retire from the Company as of June 2, 2023. In connection with Mr. Tully’s retirement, the Company and Mr. Tully entered into a Retirement Agreement, effective as of March 29, 2023 (the “Retirement Agreement”). Under the terms of the Retirement Agreement, Mr. Tully will retire from the Company on June 2, 2023 (the “Retirement Date”). Under the Retirement Agreement, Mr. Tully will receive his base salary through the Retirement Date and payment of accrued and unused vacation. Additionally, upon the Retirement Date, all of Mr.
Read the 8-K filing - Mar 10, 2023
Compensation Package for Senior Advisor On February 28, 2023, CME Group Inc. (“CME Group” or the “Company”) filed a Current Report on Form 8-K announcing that John W. Pietrowicz will retire from his position as Chief Financial Officer and Ms. Fitzpatrick will assume the role effective as of April 1, 2023. Mr. Pietrowicz will remain employed by the Company until December 31, 2023 in the role of Special Advisor. In connection with his retirement as Chief Financial Officer and his assumption of the role of Special Advisor, the CME Group Compensation Committee approved a compensation package (“Compensation Package”), effective as of April 1, 2023, for Mr. Pietrowicz. Under the Compensation Package for his services as Special Advisor, Mr.
Read the 8-K filing - Feb 28, 2023
On February 17, 2022, CME Group Inc. (“CME Group” or the “Company”) filed a Current Report on Form 8-K announcing that John W. Pietrowicz planned to retire from the position of Chief Financial Officer in 2023 and that upon Mr. Pietrowicz’s retirement, Lynne Fitzpatrick would assume the role of Chief Financial Officer. Mr. Pietrowicz will retire from his position as Chief Financial Officer and Ms. Fitzpatrick will assume the role effective as of April 1, 2023. Mr. Pietrowicz will remain employed by the Company until December 31, 2023 in the role of Special Advisor. Ms. Fitzpatrick, 44, has served as Senior Managing Director & Deputy Chief Financial Officer since February 2022.
Read the 8-K filing - Apr 14, 2022
As disclosed in CME Group Inc.’s (the “Company”) Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2022, Kevin Kometer, who previously served as our Chief Information Officer, plans to retire from the Company. In connection with Mr. Kometer’s retirement, the Company and Mr. Kometer entered into a Retirement Agreement, effective as of April 12, 2022 (the “Retirement Agreement”). Under the terms of the Retirement Agreement, Mr. Kometer will retire from the Company no later than June 1, 2022 (the “Retirement Date”). Under the Retirement Agreement, Mr. Kometer will receive his base salary through the Retirement Date, payment of accrued and unused vacation and a cash retirement payment of $500,000. Additionally, upon the Retirement Date, all of Mr.
Read the 8-K filing - Feb 17, 2022
As described in the attached press release, the Board of Directors of CME Group Inc. (“CME Group” or the “Company”) approved changes to its management team structure to position the Company for long-term success. In connection with these changes, John W. Pietrowicz, 57, who has served as our Chief Financial Officer since 2014, has announced his plans to retire in 2023. Lynne Fitzpatrick, 43, has been promoted to Deputy Chief Financial Officer and upon Mr. Pietrowicz’s retirement will assume the role of Chief Financial Officer. Ms. Fitzpatrick has served as our Managing Director, Treasurer & Head of Corporate Development since 2017. Additionally, Sunil Cutinho, 50, who has served as our President of CME Clearing since 2014, has been appointed as Chief Information Officer as the successor to Kevin Kometer who will retire from the Company in mid-2022. Mr.
Read the 8-K filing - Feb 3, 2022
On February 2, 2022, the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of CME Group Inc. (the “Company”) recommended and the Board approved an amended and restated employment agreement (the “Amended Agreement”) with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer, which extends Mr. Duffy’s current term of employment until December 31, 2024. Under the Amended Agreement, beginning January 1, 2022, Mr. Duffy’s annual base salary increased from $1,500,000 to $2,000,000. No changes were made to Mr. Duffy’s annual target bonus opportunity under the Company’s annual incentive plan or to his annual target grant date value opportunity under the Company’s omnibus stock plan. Under the Amended Agreement, if Mr. Duffy is employed by the Company on December 31, 2024, (i) Mr.
Read the 8-K filing - Feb 7, 2020
On February 6, 2020, CME Group Inc. (the “Company”) announced that Bryan T. Durkin will step down as President in May of this year. At that time, Mr. Durkin will begin serving as a special advisor to the Company, reporting to CME Group Chairman and Chief Executive Officer Terrence A. Duffy.
Read the 8-K filing
Show 12 older changes
- Dec 18, 2019
On December 16, 2019, the Compensation Committee of the Board of Directors (the “Board”) of CME Group Inc. (the “Company”) recommended and the Board approved an amended and restated employment agreement (the “Amended Agreement”) with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer, which extends Mr. Duffy’s current term from December 31, 2022 to December 31, 2023. Under the Amended Agreement, no changes were made to Mr. Duffy’s minimum annual base salary. Beginning January 1, 2020, Mr. Duffy’s (i) target bonus opportunity under the Company’s annual incentive plan will increase from 175% to 200% of Mr. Duffy’s annual base salary paid in the plan year and (ii) target grant date value opportunity under the Company’s omnibus stock plan will increase from 350% to 600% of Mr. Duffy’s annual base salary. Under the Amended Agreement, if Mr.
Read the 8-K filing - Nov 13, 2019
On November 12, 2019, Alex J. Pollock notified the Board of Directors of CME Group Inc. (the “Company”) of his intent to retire from the Company’s Board of Directors, effective as of November 15, 2019. Mr. Pollock’s decision to resign did not involve any disagreement with the Company, the Company’s management or the Board of Directors. As described in the attached press release, Mr. Pollock will be joining the U.S. Treasury Department as Principal Deputy Director of the Office of Financial Research.
Read the 8-K filing - Aug 9, 2019
On August 7, 2019, the Board of Directors of CME Group Inc. filled the vacancy in the Class B-1 director position resulting from the passing of David J. Wescott. Yra G. Harris, 66, who was a Class B-1 nominee in the 2019 annual election of directors, was appointed to fill the vacancy to serve until the next annual meeting of shareholders. Mr. Harris will receive compensation for his service on the Board of Directors on the same terms as other non-executive directors.
Read the 8-K filing - Nov 8, 2018
Following the completion of the Acquisition, on November 2, 2018, Mr. Michael Spencer, the Chief Executive Officer and a director of NEX Group, was appointed to the board of directors of the Company (“Board”). Pursuant to an amended employment agreement, entered into by and among Mr. Spencer, the Company, and NEX, Mr. Spencer has been initially appointed to the Board until the Company’s next annual meeting and it is anticipated that the Board will nominate him for re-election at the Company’s 2019 annual meeting. During the term of his amended employment agreement, Mr. Spencer will not receive any compensation for his service on the Board, other than the reimbursement of certain expenses available to all directors. With respect to those relationships and related party transactions with the Company that are required to be disclosed pursuant to Item 404(a) of Regulation S-K, Mr.
Read the 8-K filing - May 9, 2018
On May 8, 2018, the Compensation Committee of the Board of Directors (the “ Board ”) of CME Group Inc. (the “ Company ”) recommended and the Board approved an amended and restated employment agreement (the “ Amended Agreement ”) with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer, which extends Mr. Duffy’s current term from December 31, 2020 to December 31, 2022 on substantially the same terms as his existing agreement. No changes were made to Mr. Duffy’s minimum annual base salary, target bonus opportunity or target grant date value opportunity. Under the Amended Agreement, if Mr. Duffy is employed by the Company on December 31, 2022, (i) Mr.
Read the 8-K filing - Feb 13, 2018
On February 7, 2018, Leo Melamed and John F. Sandner each notified the board of directors of CME Group Inc. (the “ Company ”) of his intent to retire from the Company’s board of directors, effective upon completion of the Company’s annual meeting of shareholders scheduled for May 9, 2018. Following their retirements from the Company’s board of directors, Mr. Melamed and Mr. Sandner will each serve as a consultant to the Company. In consideration therefor, for the first two years following Mr. Melamed’s retirement, the Company will pay Mr. Melamed $1.3 million per year. Thereafter, pursuant to the terms of his existing consulting agreement, Mr. Melamed will receive $300,000 per year in consideration for continued consulting services. For the first two years following Mr. Sandner’s retirement, the Company will pay Mr. Sandner $1 million. Following such period, Mr.
Read the 8-K filing - Dec 1, 2017
On November 30, 2017, Kimberly S. Taylor announced that she is retiring from CME Group Inc. (the “Company”). Ms. Taylor served as President, Clearing and Post-Trade Services of CME Group since 2016. Previously, she served as President, Global Operations, Technology & Risk of CME Group since 2014 and as President, CME Clearing since 2004. In connection with Ms. Taylor’s retirement, the Company and Ms. Taylor entered into a Retirement Agreement. Under the terms of the Retirement Agreement, Ms. Taylor will remain employed with the Company through December 31, 2017 (the “Retirement Date”). Under the Retirement Agreement, Ms. Taylor will receive her base salary through the Retirement Date, payment of accrued and unused vacation, a payment of $100,000 upon the signing of the Retirement Agreement and a severance payment of $1,750,000. Ms.
Read the 8-K filing - Apr 7, 2017
On April 6, 2017, James E. Oliff, a director of CME Group Inc. (the "Company") at that time, notified the Company that he would resign from the Company's Board of Directors effective immediately. Mr. Oliff's decision to resign did not involve any disagreement with the Company, the Company's management or the Board of Directors. Top of the Form
Read the 8-K filing - Feb 17, 2017
On February 15, 2017, CME Group Inc. (the “Company”) entered into a retirement agreement with Phupinder Gill, the Company’s former Chief Executive Officer, governing the terms of Mr. Gill’s retirement from the Company and his resignation from the Board of Directors of the Company and its affiliates, in each case effective December 31, 2016, as the Company previously announced in a Current Report on Form 8-K filed November 14, 2016. The following is a summary of the key terms of the retirement agreement. A copy of the retirement agreement is attached to this report as Exhibit 10.1 and is incorporated herein by reference as though fully set forth herein. The description below is only a summary of the terms of the retirement agreement and is qualified in its entirety by the complete text of the agreement itself. On December 31, 2016, under Mr.
Read the 8-K filing - Dec 9, 2016
Duffy Employment Agreement On December 7, 2016, the Compensation Committee of the Board of Directors (the "Board") of CME Group Inc. (the "Company") recommended and the Board approved a revised employment agreement with Terrence A. Duffy, the Company’s Chairman and Chief Executive Officer. The following is a summary of the key terms of this agreement, which replace Mr. Duffy’s existing agreement dated as of November 11, 2015. A copy of the new employment agreement for Mr. Duffy is attached to this report as Exhibit 10.1 and is incorporated herein by reference as though fully set forth herein. The description below is only a summary of the terms of the employment agreement and is qualified in its entirety by the complete text of the new employment agreement. Under the terms of his agreement, Mr. Duffy’s minimum annual base salary is $1,500,000. Mr.
Read the 8-K filing - Nov 14, 2016
On November 10, 2016, CME Group Inc. (the "Company" or "CME Group") announced that Phupinder S. Gill, the Chief Executive Officer of the Company, has informed the Company’s Board of Directors that he is retiring from the organization and Board, at year end, December 31, 2016. At the Board’s request, Terry Duffy has assumed the expanded role of Chairman and Chief Executive Officer. Bryan Durkin, who is currently Chief Commercial Officer of the Company, has been named President of the Company. Mr. Gill will work with Messrs. Duffy and Durkin and the Company’s management team on the transition. The Honorable Terrence A. Duffy, 58, has served as Executive Chairman and President of CME Group since 2012. Previously, Duffy served as Executive Chairman since July 2007.
Read the 8-K filing - Apr 8, 2016
On April 6, 2016, Edemir Pinto, a director of CME Group Inc. (the "Company") at that time, notified the Company that he would resign from the Company's Board of Directors effective immediately. Mr. Pinto’s decision to resign did not involve any disagreement with the Company, the Company's management or the Board of Directors. Top of the Form
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2023 · 2022
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $6.5B | $4.1B | 62.5% | $11.16 | $198.4B |
| FY2024 | $6.1B | $3.5B | 57.5% | $9.67 | $137.4B |
| FY2023 | $5.6B | $3.2B | 57.8% | $8.86 | $129.7B |
| FY2022 | $5.0B | $2.7B | 53.6% | $7.40 | $174.2B |
| FY2021 | $4.7B | $2.6B | 56.2% | $7.29 | $196.8B |
| FY2020 | $4.9B | $2.1B | 43.1% | $5.87 | $124.7B |
| FY2019 | $4.9B | $2.1B | 43.5% | $5.91 | $75.2B |
| FY2018 | $4.3B | $2.0B | 45.5% | $5.71 | $77.5B |
Former directors and officers (25)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.